This 60-minute webinar is intended for communities, providers, policy makers and advocates interested in pre-exposure prophylaxis (PrEP), HIV prevention and HIV testing. We will provide an overview of the key takeaways and guidance from the newly released WHO Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. We also touch on some of the key issues and upcoming plans for lenacapavir implementation.
Objectives
By the end of the webinar, attendees will clearly understand the new WHO recommendations on lenacapavir, the supporting evidence, key implementation considerations, and evidence gaps, empowering them to drive advocacy and informed decisions on the introduction of lenacapavir in countries.
Date and time
Thursday, 28 August 2025
13:00 – 14:00 CEST
SpeakersChair: Michelle Rodolph, WHO headquarters
Carlota Baptista da Silva, WHO headquartersLloyd Mulenga, Ministry of Health, ZambiaDanvic Rosadino, Love Yourself, PhilippinesHeather-Marie Schmidt, UNAIDSHasina Subedar, National Department of Health, South AfricaOlakunle Taiwo, Ministry of Health, NigeriaWebinar series
This is the first webinar in a three-part series:
Part 2 on 4 September 2025 will focus on HIV testing.Part 3 will focus on e-training for PrEP providers.
Further details about these webinars will be shared soon.